News
CEO Spotlight: Kylee Hall
Interview with Kylee Hall, chief executive of medical device maker Cylite, on joining the Main Sequence-backed company, scaling its team, and preparing a deep-tech healthcare business for a future sale.
Company
University of Cambridge
Funding history
Investors
Every investor coverage indicates participated in a round University of Cambridge raised.
What University of Cambridge bought
Companies University of Cambridge acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
Coverage
Stories naming University of Cambridge. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Key hire
Key takeaways
Tenacious Ventures introduces Dr. Madeline Mitchell, an agricultural scientist previously at Breakthrough Victoria and Food Agility, as its new investment principal, discussing deep tech, agrifood innovation and climate science.
News
Grit, strategy, and adaptability: the sportsmanship of biotech investing
A profile of Brandon Capital partner Chris Smith, tracing his path from immunology research and a Cambridge postdoc into biotech investing, with resilience lessons drawn from equestrian sport and companies Aravax and ENA Respiratory.
News
Healthy people on a healthy planet
Breakthrough Victoria's agrifood director reflects on Victoria's food-system challenges and how portfolio companies Smart Paddock, Jupiter Ionics and Eden Brew could help build a more sustainable food future.
2 deals
Gina Rinehart backs AI brain mapping startup Omniscient in $89 million Series C
Sydney neurotech firm Omniscient has banked a Series C from Gina Rinehart and Will Vicars, funding a push into the United States for its connectomics platform.